WHO Drug Information Vol. 14, No. 4, 2000
(2000; 78 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuGeneral Policy Issues
Ouvrir ce répertoire et afficher son contenuVaccines and Biomedicines
Ouvrir ce répertoire et afficher son contenuGeneral Information
Fermer ce répertoireRegulatory and Safety Matters
Afficher le documentEtanercept: serious haematological reactions
Afficher le documentInfliximab: safety restrictions
Afficher le documentPhenylpropanolamine withdrawn from drug products
Afficher le documentLabelling revision for phenylpropanolamine
Afficher le documentPhenylpropanolamine advisory to consumers
Afficher le documentPhenylpropanolamine: strengthening of patient information
Afficher le documentLevacetylmethadol and cardiac disorders
Afficher le documentBovine-derived materials and vaccines: US recommendations
Afficher le documentProducts containing human albumin
Afficher le documentStavudine and didanosine: pregnancy advisory
Afficher le documentMethysergide and cardiac valvulopathy
Afficher le documentGreater control for cisapride
Afficher le documentNew combination drug for HIV
Afficher le documentTacrolimus for atopic dermatitis
Afficher le documentLetrozole approved for advanced breast cancer
Afficher le documentAlosetron withdrawn
Afficher le documentBasiliximab: hypersensitivity reactions
Afficher le documentBudipine: cardiac reactions
Afficher le documentCapecitabine: revised data sheet
Afficher le documentBenzathine penicillin: fatal mega-unit injections
Afficher le documentDisulfiram: hepatic reactions
Afficher le documentIsoniazid and rifampicin: severe skin reactions
Afficher le documentOmeprazole-induced interstitial nephritis
Afficher le documentOzagrel sodium: kidney function disorder
Afficher le documentDrug information to the public
Afficher le documentNorthern hemisphere influenza vaccine composition
Afficher le documentATC/DDD Classification (final)
Afficher le documentATC/DDD Classification (temporary)
Ouvrir ce répertoire et afficher son contenuHerbal Medicines
Ouvrir ce répertoire et afficher son contenuPublications and Sources of Information
 

Benzathine penicillin: fatal mega-unit injections

Zimbabwe - The Medicines Control Authority has received 3 reports of death associated with benzathine penicillin injections from 3 different manufacturers.

Prior to these reports - from 1993 to 1999 - the Authority has received only one report of an adverse reaction associated with benzathine penicillin injection where a patient had fainted for about 30 seconds after administration of the injection, but recovered. No concomitant medicines were taken. It was also reported that the patient had suffered a previous adverse reaction following a penicillin injection.

It is not clear whether these cases represent a higher incidence of hypersensitivity than would normally be expected with this drug.

Reference: Drug Information Bulletin Vol. 4, No. 2, June 2000.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013